Diuretics: Nephron Sites, Mechanisms, Clinical Uses and Electrolyte Safety

Educational pharmacology review updated 10 November 2026. This material does not replace clinical evaluation, local licensing rules or patient-specific prescribing guidance. Overview Diuretics increase urinary sodium and/or water elimination through distinct nephron targets. They are used to treat volume overload, hypertension and selected electrolyte or endocrine disorders. Their pharmacologic effectiveness and toxicity depend on kidney…

Read Full News

Renal & Blood: Oral Anticoagulants and Monitoring Parameters

Introduction/Overview Brief Introduction Oral anticoagulants constitute a critical therapeutic class for the prevention and treatment of thromboembolic disorders. Their evolution from vitamin K antagonists (VKAs) to direct oral anticoagulants (DOACs) has introduced significant pharmacologic diversity, necessitating a nuanced understanding of each agent’s mechanism, pharmacokinetics, clinical indications, and safety profile. The renal and hemostatic systems are…

Read Full News

Renal & Blood: Parenteral Anticoagulants and Reversal Agents

Introduction/Overview Parenteral anticoagulants constitute a foundational component of contemporary therapeutic strategies for the prevention and treatment of thromboembolic disorders. Their rapid onset of action, controllable pharmacodynamic profiles, and compatibility with diverse patient populations render them indispensable in acute clinical settings, such as perioperative care, acute coronary syndromes, and emergent venous thromboembolism (VTE). The renal system…

Read Full News

CVS Pharmacology: Antihypertensive Therapy Guidelines

Introduction/Overview Hypertension remains a leading contributor to cardiovascular morbidity and mortality worldwide. Effective pharmacologic management is essential for reducing the risk of stroke, myocardial infarction, and heart failure. This chapter is designed to provide a structured overview of antihypertensive therapy, emphasizing evidence‑based recommendations, pharmacologic fundamentals, and patient‑centered considerations. The content is tailored for medical and…

Read Full News

CVS Pharmacology: ACE Inhibitors, Angiotensin Receptor Blockers, and the RAAS Pathway

Introduction/Overview The renin–angiotensin–aldosterone system (RAAS) represents a central endocrine pathway that regulates arterial pressure, fluid and electrolyte balance, and systemic vascular resistance. Dysregulation of this system is implicated in a variety of cardiovascular disorders including hypertension, heart failure, chronic kidney disease, and ischemic heart disease. Pharmacologic modulation of RAAS, primarily through angiotensin‑converting enzyme (ACE) inhibitors…

Read Full News

CVS Pharmacology: Diuretics including Loop, Thiazide, and Potassium-Sparing Agents

Introduction / Overview Diuretics constitute a cornerstone of cardiovascular pharmacotherapy, exerting potent influence over fluid balance, blood pressure, and electrolyte homeostasis. Their therapeutic versatility spans from the treatment of congestive heart failure (CHF) and hypertension to the management of edema secondary to hepatic or renal disease. Distinct pharmacologic classes—loop, thiazide, and potassium-sparing agents—exhibit unique mechanisms…

Read Full News

CVS Pharmacology: Drugs for Heart Failure

Introduction/Overview Heart failure (HF) represents a spectrum of clinical syndromes characterized by the inability of the myocardium to maintain adequate cardiac output. The prevalence of HF continues to rise globally, largely due to aging populations and increasing survival rates following acute cardiovascular events. Pharmacologic therapy remains the cornerstone of management, aiming to reduce morbidity, mortality,…

Read Full News